News
HMD indigenously develops revolutionary Dispojekt safety needle syringes
IMT News Desk
HMD indigenously develops revolutionary Dispojekt safety needle syringes
IMT News Desk
Aims for 60-70 per cent market share in next three years, thanks to our innovative Dispojekt syringes with safety needle
Hindustan Syringes and Medical Devices (HMD) has launched the first-of-its kind Dispojekt single use syringes with safety needle. With the revolutionary Dispojekt safety syringes, HMD aims to reduce prevalence of accidental Needle Stick Injuries (NSIs) among health workers, reduction of infection control cost and that of disposal and training, offering a long term positive financial impact on the healthcare sector.
“Equipped with a safety shield (SIP Shield), Dispojekt syringe addresses critical concerns of needle stick injuries and reaffirms our commitment as market leader towards excellence in healthcare," said Rajiv Nath, MD, HMD.
“We aim for 60-70 per cent market share in the next three years, thanks to our innovative Dispojekt,” informed the Executive Director, Sohail Nath.
“HMD believes in delivering the best at the most competitive costing. Dispojekt safety needle syringes are going to be the game changer in the Global fight against NSIs. We are aiming to initially produce 200 million syringes and needles per annum for which we have invested approximately Rs 70 cr in the first phase,” revealed Sohail.
“In the second phase, we will increase the capacity to 300 million pieces per annum by investing another Rs 10 crore to Rs 15 crore,” added Sohail, sounding buoyant over expected return on investment over the next five years as HMD is a debt-free financially strong manufacturer and the product development has been financed from internal resources without any grants.
Dispojekt safety needle syringes have been designed to be affordable for the developing world including India and are nearly half the cost of safety single use syringes used in the US and Europe where 100 percent usage is mandatory by legislation,” informed Sohail.
Recommended
Global Health Innovative Technology Fund partners with WHO
December 12, 2024
Care.fi launches AI-Enabled RCM Platform RevNow
December 12, 2024